Anticonvulsants influence on cognitive and behavioral functions


Cite item

Full Text

Abstract

The article considers influence of the basic anticonvulsants and the last generation anticonvulsants on cognitive function and behavior. It is emphasized that physicians should be mindful of the significant differences between the drugs in this group in anticonvulsants administration with regard to their effect on cognitive function, mood and behavior that may be relevant to the quality of life of patients. It is emphasized that the basic antiepileptic anticonvulsants administration, such as valproate and carbamazepine, has minimal impact on cognitive function. However, there are no sufficient data for the effects of last generation anticonvulsants emerged relatively recently, on cognitive function that requires further study in clinical trials and meta-analysis.

References

  1. Gitai DL, Romcy-Pereira RN, Gitai LL, et al. Genes and epilepsy I: epilepsy and genetic alterations. Rev Assoc Med Bras. 2008;54(3):272-78.
  2. Salzman C. New uses for lithium and anticonvulsants. Harv Rev Psychiatry 2003;11:230-44.
  3. Rosenberg JM, Salzman C. Update: new uses for lithium and anticonvulsants. CNS Spectr 2007;12:831-41.
  4. Chen H, Reeves JH, Fincham JE, et al. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry 2006;67(6):972-82.
  5. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and co-medication on patterns of use. Epilepsia 1998;39:1083-87.
  6. Morrell MJ. Stigma and epilepsy. Epilepsy Behav 2002;3(6S2):21-25.
  7. Fisher RS, Vickrey BG, Gibson P, et al. The impact of epilepsy from the patient's perspective I: descriptions and subjective perceptions. Epilepsy Res 2000;41:39-51.
  8. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44(suppl. 4):21-29.
  9. Leidy NK, Elixhauser BV, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999;53:162-66.
  10. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58(suppl. 5):21-6.
  11. American Academy of Pediatrics. Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn (RE9866). Arch Pediatr Adolesc Med 2002;156:1129-32.
  12. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 2003;993:103-14.
  13. Olney JW, Wozniak DF, Jevtovic-Todorovic V, et al. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 2002;12(4):488-98.
  14. Sulzbacher S, Farwell JR, Temkin N, et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr 1999;38:387-94.
  15. Loring D. Cognitive Side Effects of Antiepileptic Drugs in Children. Psychiatric Times 2005;25(10).
  16. Malagon-Valdez J. Cognitive effects of antiepileptic drugs. Rev Neurol 2003;36(3):288-92.
  17. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-22.
  18. Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf 2000;23:35-56.
  19. Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002;8(1):45-58.
  20. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-90.
  21. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002;22(3):285-93.
  22. Buffett-Jerrott SE, Stewart SH, Finley GA, Loughlan HL Effects of benzodiazepines on explicit memory in a paediatric surgery setting. Psychopharmacology 2003;168(4):377-86.
  23. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.
  24. Gillham RA, Williams N, Wiedmann KD, et al. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res 1990;7:219-25.
  25. Macphee GJA, Goldie C, Roulston D, et al. Effect of carbamazepine on psychomotor performance in naive subjects. Eur J Clin Pharmacol 1986;30:37-42.
  26. Seidel WT, Mitchell WG. Cognitive and behavioral effects of carbamazepine in children: data from benign rolandic epilepsy. J Child Neurol 1999;14(11):716-23.
  27. Frost JD Jr, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol 1995;12(1):57-63.
  28. Bailet LL, Turk WR. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia 2000;41(4):426-31.
  29. Wallace SJ. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf 1996;15:378-93.
  30. Reynolds E.H. Folic acid, ageing, depression, and dementia. BMJ 2002;324;1512-5.
  31. Trimble MR. Cognitive hazards of seizure disorders. Epilepsia 1988;29(Suppl):S19-S24.
  32. Hernandez R, Fernandez Mde L, Miranda G, Suastegui R. Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study. Rev Invest Clin 2005;57:522-31.
  33. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52(2):321-7.
  34. Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: The Treatment of Epilepsy, Wyllie E, ed. Baltimore: Williams & Wilkins, 2005.
  35. Ochoa JG, Riche W. Antiepileptic Drugs: An Overview. Updated: Dec 11, 2008. http://emedicine.medscape.com/article/1187334-overview.
  36. Mecarelli O, Vicenzini E, Pulitano P, et al. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother 2004;38(11):1816-22.
  37. Aikia M, Kalvianen R, Sivenius J, et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow up. Epilepsy Res 1992;11:199-203.
  38. Donati F, Gobbi G, Campistol J, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 2007;16(8):670-79.
  39. Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition: a doubleblind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997; 62(4):372-6.
  40. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40(9):1279-85.
  41. Salinsky MC, Binder LM, Oken BS, et al. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002;43(5):482-90.
  42. Dodrill CB, Arnett JL, Shu V, et al. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia 1998;39(1):33-42.
  43. Aikia M, Jutila L, Salmenpera T, Mervaala E, Kalviainen R. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. Epilepsia 2006;47(7):1121-27
  44. Fritz N, Glogau S, Hoffmann J, et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005;6(3):373-81.
  45. Provinciali L, Bartolini M, Mari F, et al. Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy. Acta Neurol Scand 1996;94(1):12-8
  46. Camposano SE, Major P, Halpern E, Thiele EA. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia 2008;49(7):1186-91.
  47. Mecarelli O, Vicenzini E, Pulitano P, et al. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother 2004;38(11):1816-22.
  48. Rugino TA, Samsock TC. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr 2002;23(4):225-30.
  49. Arif H, Buchsbaum R, Weintraub D, et al. Patient-reported cognitive side effects of antiepileptic drugs: Predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav 2008.
  50. Tatum WO, French JA, Faught E, et al. Postmarketing experience with topiramate and cognition. Epilepsia 2001;42:1134-1140.
  51. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003;44:339-47.
  52. Dooley JM, Camfield PR, Smith E, et al. Topiramate in intractable childhood onset epilepsy - a cautionary note. Can J Neurol Sci 1999; 26(4):271-73.
  53. Kang HC, Eun BL, Wu Lee C, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 2007;48(9):1716-23.
  54. Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 2003;54(2-3):171-78.
  55. Lossius MI, Hessen E, Mowinckel P, et al. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia 2008;49(3):455-63.
  56. Hessen E, Lossius MI, Reinvang I, Gjerstad L. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy. Epilepsy Behav 2007;10(3):449-55.
  57. Elixhauser A, Leidy NK, Meador K, Means E, Willian MK. The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy. Epilepsy Res 1999;37:13-24.
  58. Khan A, Ginsberg LD, Asnis GM, et al. Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder. J Clin Psychiatry 2004;65(11):1483-90.
  59. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2276&mid=1085056570&magid=170

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies